Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) - XML Representation

Raw xml | Download

<ArtifactAssessment xmlns="http://hl7.org/fhir">
  <id value="179693"/>
  <meta>
    <versionId value="12"/>
    <lastUpdated value="2025-09-13T09:36:24.241Z"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/certainty-of-evidence"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-assessment"/>
  </meta>
  <text>
    <status value="additional"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p>Low certainty evidence (GRADE)</p></div>
  </text>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/artifact-description">
    <valueMarkdown
                   value="This example of a CertaintyOfEvidence Profile shows a recursive pattern of component elements with type/classifier paired values for different aspects of rating the certainty of evidence."/>
  </extension>
  <extension
             url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
    <valueCodeableConcept>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
        <code value="active"/>
        <display value="Active"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net/FOI"/>
    <value value="179693"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <title
         value="Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)"/>
  <citeAs
          value="Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [Database Entry: FHIR ArtifactAssessment Resource]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179693. Revised 2025-09-13. Available at: https://fevir.net/resources/ArtifactAssessment/179693. Computable resource at: https://fevir.net/resources/ArtifactAssessment/179693#json."/>
  <artifactReference>🔗 
    <reference value="Evidence/55"/>
    <type value="Evidence"/>
    <display
             value="14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)"/>
  </artifactReference>
  <content>
    <type>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="rating-system"/>
        <display value="Rating System"/>
      </coding>
    </type>
    <classifier>
      <coding>
        <system
                value="http://hl7.org/fhir/uv/ebm/CodeSystem/evidence-rating-system-classifier-codesystem"/>
        <code value="GRADE"/>
        <display value="GRADE"/>
      </coding>
    </classifier>
    <freeToShare value="true"/>
  </content>
  <content>
    <type>
      <coding>
        <system value="http://hl7.org/fhir/certainty-type"/>
        <code value="Overall"/>
        <display value="Overall certainty"/>
      </coding>
    </type>
    <classifier>
      <coding>
        <system value="http://hl7.org/fhir/certainty-rating"/>
        <code value="low"/>
        <display value="Low quality"/>
      </coding>
    </classifier>
    <freeToShare value="true"/>
  </content>
</ArtifactAssessment>